The cell culture sampling devices market is anticipated to flourish at a steady CAGR of 10.8% between 2023 and 2033. The market is expected to hold a market share of USD 7.80 billion by 2033, while the market is likely to reach a value of USD 2.79 billion in 2023.
| Attributes | Details |
|---|---|
| Cell Culture Sampling Devices Market CAGR (2023 to 2033) | 10.8% |
| Cell Culture Sampling Devices Market Size (2023) | USD 2.79 billion |
| Cell Culture Sampling Devices Market Size (2033) | USD 7.80 billion |
The demand for cell culture sampling devices is likely to increase due to being widely used in the biopharmaceutical industry during the forecast period. Moreover, cell culture sampling devices provide suitable conditions or environments in which microorganisms can grow efficiently and produce a target product.
In the cell culture process, the prokaryotic cell is developed in ex-vivo conditions where cell culture sampling devices provide an artificial habitat in an under-regulated lab environment. Due to its widespread use in laboratories, the sales of cell culture sampling devices are likely to rise in recent years.
Cell culture helps the researcher in the production of medicinal drugs, biomolecules, and research studies and is believed to be one of the most important scientific equipment in the niche it serves. Moreover, cell biomass and metabolites are the key product produced via cell culture sampling devices. The metabolites perform activities like fuel, signaling, stimulatory, and other effects on enzymes, ultimately increasing the catalytic activity. This is anticipated to boost the cell culture sampling devices market in the coming period.
The technological advancement in the field helps various industries to produce their product on a large scale over conventional cell culture sampling devices. This advanced technology is likely to increase the application of cell culture sampling devices during the forecast period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The cell culture sampling devices can stimulate the growth of the mechanized large-scale cell culture with purity and high efficiency. This is expected to increase the demand for cell culture sampling devices over the forecast period.
The cell culture sampling devices market share is likely to increase in various industries, including the biopharmaceutical industry, clinic research, laboratory, and research & development activities. The strategic collaboration between manufacturers and researchers and market consolidation is likely to increase the demand for these devices. Fewer chances of contamination, improved system flexibility, and reduction in cleaning steps are further fueling their sales.
However, high maintenance with a requirement for huge capital investment to establish a cell culture research lab might put some restraints on the sales of cell culture sampling devices. In addition, the lack of highly skilled professionals can pose further challenges to the cell culture sampling devices market all around the region during the forecast period.
| Countries | Revenue Share % (2022) |
|---|---|
| United States | 36.2% |
| Germany | 8.9% |
| Japan | 2.8% |
| North America | 39.6% |
| Europe | 33.1% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 11.4% |
| India | 10.4% |
| United Kingdom | 8.9% |
| Australia | 9.3% |
North America is likely to continue to dominate the global cell culture sampling devices market share attributed to the growth in research laboratories and increasing demand for biologic drugs.
Furthermore, the newly developed technology in cell culture sampling devices is also expected to result in higher demand. Thus, North America held a 39.6% market share in 2022, and during the forecast period as well, the region is expected to display formidable growth.
Government investments in the healthcare sector are anticipated to increase the market share in Europe. In addition, Europe is a hotspot for technological advancements. The presence of technologically advanced healthcare sectors, especially in the United Kingdom, is accelerating market growth.
The efficient operating cost of industries and laboratories is another factor contributing to the sales of cell culture sampling devices. Thus, Europe possessed a 33.1% market share of the cell culture sampling devices market in 2022.
| Category | By Application Type |
|---|---|
| Leading Segment | Biopharmaceuticals |
| Market Share (2022) | 31.3% |
| Category | By End User |
|---|---|
| Leading Segment | Biopharmaceutical Companies |
| Market Share (2022) | 57.8% |
The cell culture sampling devices start-ups are innovating various sampling devices which are easy to use in research labs and institutions. They are developing tools with highly advanced technology for quick results in the study of molecular biology, metabolic studies, and others, thus creating a robust cell culture sampling devices market.
The higher involvement of these start-ups may likely open new ways to adopt the existing sampling devices, as a result of which the demand for cell culture sampling devices might surge in the coming times.
Some key start-ups in the cell culture sampling device market are Allogene Therapeutics, TreeFrog Therapeutics, BlueRock Therapeutics, Regeneron, and Membio.
Membio, a Canadian start-up, offers sampling devices that enable unlimited production in a sustainable and scalable way and carry out the activities efficiently pertaining to cell culture sampling.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The cell culture sampling devices market is fragmented by the several key vendors present in the market to lift the market share of cell culture sampling devices. These players are using various tactics to acquire the lion's market share in recent years. Some popular marketing methods key players adopt are mergers, collaborations, partnerships, product launches, acquisitions, and others during the forecast period.
Recent Developments
Key Players
The market is expected to be valued at USD 2.7 billion in 2033.
Thermo Fisher Scientific and Merck & Co. Inc. are key market players.
The United States generated a 36.2% revenue in 2022.
Growing demand from the biopharmaceutical industry to boost the market prospects.
China to expand at a CAGR of 11.4% through 2033.
| Estimated Market Size (2024E) | USD 27,911.3 million |
|---|---|
| Market Value (2034F) | USD 44,593.1 million |
| Value-based CAGR (2024 to 2034) | 4.7% |
| Market Value (2023) | USD 2,315.5 million |
|---|---|
| Expected Value (2033) | USD 4,305.1 million |
| Projected CAGR (2023 to 2033) | 6.4% |
Explore Life Science & Biotechnology Insights
View Reports
Cell Culture Sampling Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
